National Eye Institute Visual Function Questionnaire-25
Also known as: VFQ-25
The NEI-VFQ-25 is a 25-item self-report questionnaire measuring the impact of vision loss on health-related quality of life across multiple functional and psychological domains. Developed by the National Eye Institute (Mangione et al., 2001), it is the most widely used vision-specific QoL instrument in ophthalmology and serves as the gold standard for quantifying patient-reported visual disability across diverse eye conditions.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Appropriate for any patient with vision loss or ocular disease for whom subjective functional and QoL impact matters. Particularly valuable in chronic conditions (glaucoma, AMD, diabetic retinopathy) where visual acuity is stable but QoL declines, or conversely where small VA gains produce large QoL improvements. Recommended at baseline, during treatment, and at follow-up to track change. Essential in shared decision-making: reveals whether a treatment prioritizes the patient's real-life needs.
Strengths & limitations
- Psychometrically robust: excellent internal consistency (Cronbach α 0.70–0.94 across subscales), test-retest reliability (ICC >0.80), and convergent/discriminant validity
- Disease-agnostic: sensitive across cataract, glaucoma, AMD, diabetic retinopathy, low vision, and refractive error—enabling comparison across diagnostic categories
- Multidimensional: 12 subscales capture distinct QoL domains; clinicians are not forced to reduce vision to a single number
- Responsive to change: demonstrates meaningful improvement/decline with treatment, surgery, or disease progression with good effect sizes (Cohen d often >0.5 for surgical interventions)
- Extensively validated: thousands of publications, translation to 40+ languages, normative data available, adopted by FDA and EMA in clinical trial guidance
- Floor and ceiling effects on some subscales (e.g., Peripheral Vision, Eye Pain) reduce sensitivity in mild disease or intact peripheral vision
- Requires literacy and cognitive capacity; not validated in non-English for all translations; telephone administration possible but less reliable than self-report
- Does not directly measure vision itself (VA, VF, contrast sensitivity)—QoL perception may diverge from objective metrics due to adaptation, depression, or expectations
- Subscale correlations are moderate to high, suggesting some redundancy; factor structure has been debated, and alternative scoring methods exist
Frequently asked
What is a clinically meaningful change in NEI-VFQ-25 score?
The MCID depends on the subscale and context. General guidance: a change of 5–10 points on a subscale is considered clinically important; composite score changes of 5–15 points reflect meaningful improvement/decline. In cataract surgery, patients typically improve 15–25 points overall. Smaller improvements (3–5 points) in glaucoma or AMD reflect slower disease trajectories.
Can NEI-VFQ-25 be used in patients with severe low vision or blindness?
Yes. Although VA is 20/200 or worse, patients retain functional vision and subjective experience. The VFQ-25 captures residual near and distance activities, peripheral vision use, and emotional impact. In blind patients (no light perception), most items may yield floor scores, but it still documents QoL burden. For severe low vision, the VFQ-25 is more informative than VA alone.
How is the overall composite score calculated?
The composite is the unweighted mean of all 12 subscale scores (each converted to 0–100). If a subscale has missing data, imputation protocols (e.g., average of completed subscales in that patient) apply. The overall score ranges 0–100, with higher = better function. Some analyses use weighted composites; check your instrument documentation.
Is NEI-VFQ-25 available freely, and who can administer it?
The instrument is free for research and clinical use with minimal restrictions. No special license or training required—any healthcare provider or trained administrator can give it. In the US and many countries, it is in the public domain. Always cite Mangione et al. (2001) in publications.
Sources
- Mangione, C. M., Lee, P. P., Gutierrez, P. R., et al. (2001). Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol, 119(7), 1050-1058. DOI: 10.1001/archopht.119.7.1050 ↗
- Mangione, C. M., Berry, S., Spritzer, K., et al. (1998). Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol, 116(2), 227-233. DOI: 10.1001/archopht.116.2.227 ↗
How to cite this page
ScholarGate. (2026, June 3). National Eye Institute Visual Function Questionnaire-25. ScholarGate. https://scholargate.app/en/ophthalmology/nei-vfq-25
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- GQL-15Ophthalmology↔ compare
- LVQOLOphthalmology↔ compare
- OSDIOphthalmology↔ compare
- VF-14Ophthalmology↔ compare